OriCell’s Ori-C101 Advances to Phase II Trial in Liver Cancer
SHANGHAI, China, June 8, 2026 OriCell Therapeutics has achieved a major regulatory and clinical milestone with the National Medical...
Hepatocellular Carcinoma
Advertisement
Greywolf Reports Durable Responses with First-in-Class ERAP1 Inhibitor
OXFORD, UK, May 22, 2026 Greywolf Therapeutics announced encouraging clinical results from the Phase 1b portion of its ongoing...
GSK’s Bepirovirsen Delivers Landmark Phase 3 Cure Data
LONDON, UK, May 28, 2026 GSK has announced groundbreaking Phase III clinical trial results for bepirovirsen, its investigational antisense...
Callio Therapeutics Advances CLIO-8221 Phase 1 Trial for HER2 Tumors
SEATTLE and SINGAPORE, May 27, 2026 Callio Therapeutics has announced the presentation of its Phase 1 clinical trial design...
Roche Launches AI-Powered Liver Disease Panel for Early Detection
BASEL, Switzerland, May 27, 2026 Roche has announced the launch of its groundbreaking Liver Disease Panel, the healthcare industry’s...
Advertisements
Rznomics Announces FDA RMAT Designation for RZ-001 in Hepatocellular Carcinoma
SEOUL, South Korea, May 8, 2026 Rznomics announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative...
Ribo and Boehringer Advance siRNA MASH Program
SUZHOU, China, May 6, 2026 Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB announced the achievement of...
HelioLiver Blood Test Shows Strong HCC Detection
IRVINE, Calif., May 6, 2026 Helio Genomics announced publication of landmark clinical data demonstrating that its HelioLiver™ multi-analyte blood...
Rznomics RZ-001 Shows Strong HCC Clinical Data AACR
SAN DIEGO, Calif., April 19, 2026 Rznomics Inc. announced encouraging interim clinical results from its ongoing study of RZ-001,...
Sirtex Medical Reports 100% Tumor Control in DOORwaY90
Woburn, Massachusetts | April 13, 2026 Sirtex Medical has announced groundbreaking results from its DOORwaY90 clinical study, demonstrating 100%...
Advertisement
